PROGRAMMED CELL-DEATH IN THE DYSMYELINATING MUTANTS

被引:49
作者
SKOFF, RP
机构
[1] Department of Anatomy and Cell Biology, Wayne State University School of Medicine, Detroit, Michigan
关键词
D O I
10.1111/j.1750-3639.1995.tb00605.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A large number of genetic mutants that are missing a particular myelin protein or that have an aberrant myelin protein composition have been described. These mutations usually cause dysmyelination in the PNS or CNS. Similarly, the nervous system of animals experimentally altered to block synthesis of myelin proteins have recently been generated that show aberrations in the myelin sheath. For both groups of animals, the numbers of myelinating cells remain relatively stable and glial cell death is minimal. The exception is animals with mutations in the proteolipid protein (PLP) gene which exhibit extensive death of oligodendrocytes (OLs). The degree of OL death in the PLP mutants generally correlates with the amount of dysmyelination. Dying OLs in the PLP mutants exhibit the classical features of apoptotic cells. Programmed cell death (PCD) is often, but not necessarily, manifested by cleavage of DNA into abundant oligonucleosomal fragments. Detection of these abundant DNA fragments was examined in normal and jimpy (jp) mice using the TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) method. In normal spinal cord and brain, at least twice as many cells exhibited DNA fragmentation when compared to numbers of pyknotic glia observed microscopically. In jp spinal cord and brain, roughly one-half of cells exhibited DNA fragmentation when compared to numbers of pyknotic glia observed microscopically. PCD of cells in normal development involving DNA fragmentation has been previously described and our results support that conclusion. The data obtained from the jp mice suggests that the mechanism of apoptosis due to PLP mutations is somewhat different from that which occurs in normal development.
引用
收藏
页码:283 / 288
页数:6
相关论文
共 38 条
[1]  
Barres BA, Hart IK, Coles HSR, Burne JF, Voyvodic JT, Richardson WD, Raff MC, Cell death and control of cell survival in the oligodendrocyte lineage, Cell, 70, pp. 31-46, (1992)
[2]  
Bartlett WP, Knapp PE, Skoff RP, Glial conditioned medium enables jimpy oligodendrocytes to express properties of normal oligodendrocytes: production of myelin antigens and membranes, Glia, 1, pp. 253-259, (1989)
[3]  
Billings-Gagliardi S, Adcock LH, Wolf MK, Hypomyelinated mutant mice: description of jpmsd and comparison with jp and qk on their present genetic backgrounds, Brain Research, 194, pp. 325-338, (1980)
[4]  
Billings-Gagliardi S, Kirschner D, Lane P, Nadon N, Stanhope G, Wolf MK, A new X‐linked myelin mutant mouse, Soc Neurosci Abstr, 18, (1992)
[5]  
Cohen GM, Sun X-M, Snowden RT, Dinsdale D, Skilletter DN, Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation, Biochem J, 286, pp. 331-334, (1992)
[6]  
Collins RJ, Harmon BV, Gabe GC, Kerr JFR, Internucleosomal DNA cleavage should not be the sole criterion for identifying apoptosis, Int J Rad Biol, 61, pp. 451-453, (1992)
[7]  
Duvall E, Wyllie AH, Death and the cell, Immunol Today, 74, pp. 29-56, (1986)
[8]  
Dyer CA, Philibotte TM, Billings-Gagliardi S, Wolf MK, Cytoskeleton in myelin‐basic protein‐deficient shiverer oligodendrocytes, Dev Neurosci, 17, pp. 53-62, (1995)
[9]  
Fanarraga ML, Griffiths IR, McCulloch MC, Barrie JA, Kennedy PGE, Brophy PJ, Rumpshaker: An X‐linked mutation causing hypomyelination: Developmental differences in myelination and glial cells between the optic nerve and spinal cord, Glia, 5, pp. 161-170, (1992)
[10]  
Friedrich VL, Hyperplasis of oligodendrocytes in quaking mice, Anat Embryol, 147, pp. 259-271, (1975)